Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
Dana-Farber Cancer Institute
Mar 24, 2024, 08:23 |
Drugs
Paolo Tarantino: Adding palbociclib to fulvestrant did not improve PFS in the PACE randomized phase 2 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 22, 2024, 06:12 |
Drugs
Paolo Tarantino: We’re running SATEEN, the first trial of sacituzumab govitecan + trastuzumab in patients with HER2 + MBC
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post by Marta…
Mar 15, 2024, 18:24 |
Drugs
Paolo Tarantino: Final analysis of the PEONY phase 3 trial
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 13, 2024, 16:19 |
Blog
Toni Choueiri: The April ASCO Plenary Series are here
Toni Choueiri shared the following post on X: "The April ASCO Plenary Series are here:…
Mar 12, 2024, 00:33 |
Blog
Paolo Tarantino: Such a well deserved award for Reshma Mahtani
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 11, 2024, 00:01 |
Blog
Laurie Glimcher: We are proud to be among the nation’s leading health care services
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X: "We are proud…
Mar 5, 2024, 14:37 |
Blog
Paolo Tarantino: Interesting read on many recent deals in the ADC field
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 4, 2024, 17:58 |
Insight
Paolo Tarantino: You don’t always need a fancy new drug to impact patients QoL
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
Mar 4, 2024, 17:11 |
Blog
Laurie Glimcher: It is an honor to be recognized among so many talented leaders on the 2024 STATUS list
Laurie Glimcher, President and CEO of Dana-Farber Cancer Institute, shared on X/Twitter: “It is an…
Mar 1, 2024, 02:50 |
Blog
Paolo Tarantino: A round of virtual applause to Hiroji Iwata for chairing what has been a truly remarkable JSMO24!
Paolo Tarantino, Medical Oncologist and Research Fellow at Dana-Farber Cancer Institute, shared a post on…
63
64
65
66
67
All:
748
Posts:
641 - 650
Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024
Jeff Bridges and Lymphoma: How He Went Against, How He Survived, and More
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 5
Familial Adenomatous Polyposis: Alarming Symptoms, Causes, Types, Diagnosis and Treatment
OncoDaily Party Barcelona
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube